Kailera Therapeutics (KLRA) Institutional Ownership

Kailera Therapeutics logo
$12.20 -0.37 (-2.94%)
As of 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Kailera Therapeutics (NASDAQ:KLRA)

Number of
Institutional Buyers
(last 12 months)
15
Total
Institutional Inflows
(last 12 months)
$260.94M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$566.93K
Get KLRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kailera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KLRA Institutional Buying and Selling by Quarter

Kailera Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2026 Goldman Sachs Group Inc.696,577$7.96M0.0%+65.4%0.536%
11/15/2026 Jump Financial LLC381,002$4.35M0.0%N/A0.293%
11/14/2026 Marshall Wace LLP878,196$10.03M0.0%N/A0.676%
11/12/2026 State Street Corp2,241,320$25.60M0.0%+158.2%1.726%
11/10/2026 Cibc World Market Inc.37,181$425K0.0%+4.8%0.029%
11/6/2026 Aberdeen Group plc432,661$4.94M0.0%+209.0%0.334%
11/6/2026 Russell Investments Group Ltd.3,673$42K0.0%-93.1%0.003%
11/3/2026 Alps Advisors Inc.171,739$1.96M0.0%+31.1%0.132%
11/2/2026 Commonwealth Equity Services LLC11,713$134K0.0%N/A0.009%
10/29/2026 Profund Advisors LLC18,880$216K0.0%N/A0.015%
10/9/2026 Mirador Capital Partners LP58,284$666K0.1%N/A0.045%
9/22/2026 State Street Corp868,160$19.13M0.0%N/A0.670%
9/9/2026 Tidal Investments LLC14,039$309K0.0%N/A0.011%
9/9/2026 Squarepoint Ops LLC45,062$993K0.0%N/A0.035%
8/23/2026 Frazier Life Sciences Management L.P.1,100,000$24.23M0.5%N/A0.849%
8/21/2026 Atlas Venture Life Science Advisors LLC5,171,282$113.92M12.9%N/A3.989%
8/19/2026 Wellington Management Group LLP2,919,110$64.31M0.0%N/A2.252%


KLRA Institutional Ownership - Frequently Asked Questions

During the previous two years, 16 institutional investors and hedge funds held shares of Kailera Therapeutics. The most heavily invested institutionals were Atlas Venture Life Science Advisors LLC ($113.92M), Wellington Management Group LLP ($64.31M), State Street Corp ($25.60M), Frazier Life Sciences Management L.P. ($24.23M), Marshall Wace LLP ($10.03M), Goldman Sachs Group Inc. ($7.96M), and Aberdeen Group plc ($4.94M).Learn more on Kailera Therapeutics' institutional investors.

Of the 15 institutional investors that purchased Kailera Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Atlas Venture Life Science Advisors LLC ($5.17M), Wellington Management Group LLP ($2.92M), State Street Corp ($2.24M), Frazier Life Sciences Management L.P. ($1.10M), Marshall Wace LLP ($878.20K), Jump Financial LLC ($381.00K), and Aberdeen Group plc ($292.66K).

Institutional investors have bought a total of 13,449,536 shares in the last 24 months. This purchase volume represents approximately $260.94M in transactions.

The following institutional investors have sold Kailera Therapeutics stock in the last 24 months: Russell Investments Group Ltd. ($49.64K).

Institutional investors have sold a total of 49,644 shares in the last 24 months. This volume of shares sold represents approximately $566.93K in transactions.



Institutional ownership data for NASDAQ:KLRA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 11/17/2026. New 13F filings are added each quarter as they're published.
From Our Partners